MOHW saving plans from NHI drugs in failure.

Published: 2001-11-29 07:00:00

Updated: 2001-11-29 07:00:00

In the interim report over the NHI financial stabilization measures the MOHW revealed that the 60 billion won of NHI saving plan from drugs seems to go failure largely due to the market avoidance of substituted dispensing and the postponed implementation of the reference price system.

Mr. Lee...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK